OBA-PHARMA ApS: Financial statements 2014
CVR: 19995607
Source: annual report 2014, Danish Business Authority
01/10/2013 – 30/09/2014
OBA-PHARMA ApS (CVR 19995607) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 3,664,804 and a net result of DKK 3,119,719 compared with DKK 2,356,113 the year before. That is an increase of 26.3% compared with the year before. Equity in the 2014 report amounted to DKK 3,598,404. The solvency ratio was 54.9%.
- Gross Profit
- DKK 3,664,804
- Profit/Loss
- DKK 3,119,719
- Equity
- DKK 3,598,404
- Total Assets
- DKK 6,553,510
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 3.7 mio. | 3.1 mio. | 3.6 mio. | - |
| 2013 | - | 2.9 mio. | 2.4 mio. | 3 mio. | - |
| 2012 | - | 3 mio. | 2.2 mio. | 7.6 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
OBA-PHARMA ApS has published its annual report for 2013. Gross profit came to DKK 2,900,864, and the net result was DKK 2,356,113.
About OBA-PHARMA ApS
OBA-PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PBH 25.376 ApS. The management consists of Malene Dybdahl Birch. The company is owned by LEV-VEL ApS and NLDB Holding ApS. The company has 0 employees (2000). In 2024, the company reported a gross profit of DKK 3,402,201 and a net result of DKK 2,670,973 compared with DKK 2,073,440 the year before. Equity in the 2024 report amounted to DKK 674,251.